A phase i study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma

Andrea Wang-Gillam, Stacey Plambeck-Suess, Peter Goedegebuure, Peter O. Simon, Jonathan B. Mitchem, John R. Hornick, Steven Sorscher, Joel Picus, Rama Suresh, Albert C. Lockhart, Benjamin Tan, Williams G. Hawkins

Research output: Contribution to journalArticlepeer-review

58 Scopus citations

Fingerprint Dive into the research topics of 'A phase i study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences